Biosensor markets: opportunities and obstacles.
Currently, glucose sensing for the control of diabetes is the only high-volume market for biosensors. Yet, a variety of lower-volume niches are available for exploitation in medical diagnostics and the pharmaceutical and other industries. There are problems waiting for biosensor solutions, but the balance between market opportunities and technical and/or financial obstacles will control the future expansion of biosensor technology.